Finance

Beta
Lists
VAISHALI:NSE
Vaishali Pharma Ltd
â‚ą7.72
+1.71%
(+0.13) 1D
Jun 22, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VAISHALI...
Open
â‚ą7.70
High
â‚ą7.89
Low
â‚ą7.26
Mkt. cap
1.01B
Avg. vol.
92.59K
Volume
85.90K
P/E ratio
24.12
52-wk high
â‚ą13.59
52-wk low
â‚ą4.75
EPS
â‚ą0.32
No. of employees
27
Open
â‚ą7.70
High
â‚ą7.89
Low
â‚ą7.26
Mkt. cap
1.01B
Avg. vol.
92.59K
Volume
85.90K
P/E ratio
24.12
52-wk high
â‚ą13.59
52-wk low
â‚ą4.75
EPS
â‚ą0.32
No. of employees
27
News stories
From sources across the web
About Vaishali Pharma Ltd
CEO-
Employees27
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitevaishalipharma.com
Last report
May 30, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
269.27M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
237.47M
334.46M
246.52M
269.27M
Cost of goods sold
200.32M
296.97M
209.37M
244.57M
Cost of revenue
200.32M
296.97M
209.37M
244.57M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.84M
6.32M
7.22M
7.76M
Operating expense
24.90M
25.32M
22.82M
28.32M
Total operating expenses
225.22M
322.28M
232.19M
272.89M
Operating income
12.25M
12.18M
14.33M
-3.62M
Other non operating income
8.42M
8.39M
8.92M
12.62M
EBT including unusual items
17.35M
16.58M
18.33M
2.94M
EBT excluding unusual items
17.35M
16.58M
18.33M
2.94M
Income tax expense
4.56M
4.72M
5.15M
-869.00K
Effective tax rate
26.28%
28.44%
28.09%
-29.55%
Other operating expenses
15.63M
17.28M
14.33M
18.97M
Net income
12.79M
11.86M
13.18M
3.81M
Net profit margin
5.39%
3.55%
5.35%
1.41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-3.32M
-4.01M
-5.08M
-7.21M
Net interest expenses
-3.32M
-4.01M
-5.08M
-7.21M
Depreciation and amortization charges
1.42M
1.72M
1.27M
1.59M
EBITDA
13.47M
12.79M
14.94M
-3.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer